- Home
- / Exopharm
Exopharm
Stock Price
$0
2024-05-10
Market Capitalization
$1.9 M
2024-05-10
Exopharm Summary
Company Summary
- Overview
- Exopharm is a biopharmaceutical company that specializes in the development of genetic medicines. It offers engineered extracellular vesicles (EEVs) for neurology, cardiology, and oncology therapeutic areas.
- Type
- Public
- Status
- Active
- Founded
- 2013
- Website
- https://exopharm.com
- Cybersecurity rating
Table of Contents
Exopharm Financials
Summary Financials
- Net income (H1, 2026)
- ($3.4M)
- Cash (H1, 2026)
- $6.4M
- EBIT (H1, 2026)
- ($3.5M)
- Enterprise value
- ($3.8M)
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026